부가기능
The Effects of Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-Gamma Agonist, on Markers of Endothelial Cell Activation, C-Reactive Protein, and Fibrinogen Levels in Non-Diabetic Coronary Artery Disease Patients/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.